jhampton+FollowNektar’s Skin Drug Buzz: Should You Jump In?Nektar’s stock just shot up after-hours because they’re about to drop big news on a new eczema treatment. If you’ve ever dealt with itchy skin or know someone who has, this could be a game-changer. The hype is real—message boards are blowing up, and some folks are betting the stock will keep climbing. But with the company’s recent losses, some investors are playing it safe and cashing out early. Would you ride the wave or lock in your gains? #stocks #biotech #investing #Business #Market10Share
Allen Rios+FollowMAIA & Roche: Cancer Fighters Team Up!MAIA just teamed up with pharma giant Roche to try a new combo for tough-to-treat cancers, and their stock jumped 12%! The buzz? MAIA’s new drug could make Roche’s cancer treatment even stronger, giving hope to patients who’ve run out of options. Retail investors are suddenly way more optimistic, even though the stock’s had a rough year. Sometimes, all it takes is a big partnership to turn the mood around! #stocks #investing #biotech #Business #Market10Share
Joseph Bradley+FollowExosomes: Cancer’s Double Agent?Exosomes are the tiny messengers in our bodies that can either help fight cancer or help it hide! Some companies are engineering these vesicles to deliver cancer-killing drugs, while others are finding ways to stop exosomes from helping tumors grow, spread, or dodge the immune system. The wild part? Exosomes are also showing up as new cancer biomarkers and precision drug carriers. The future of cancer treatment might just ride on these microscopic couriers! #CancerResearch #Immunotherapy #Exosomes #Biotech #HealthInnovation #Health222Share
Zachary Gutierrez+FollowTwo Dads, One Mouse: Science Just Did ThatScientists just pulled off a wild first: they raised a healthy mouse that came from two male parents—no mom needed! By tweaking certain genes, they cracked the code that usually blocks this kind of development. This could totally shake up cloning, stem cell research, and maybe even future treatments for rare genetic diseases. It’s a huge leap for biology, but don’t expect human versions anytime soon—there are still a ton of ethical and safety questions to answer. #ScienceNews #Genetics #Biotech #Science80Share
martinezlaura+FollowIs There a State Beyond Life & Death?Scientists might’ve just found a wild 'third state' between life and death! Apparently, some cells can keep living and even turn into new 'living robots' after the rest of the body dies. These aren’t zombie cells—they’re more like tiny, self-healing bots that can repair neurons and move around. It’s blowing scientists’ minds and could totally change how we think about life, death, and what comes after. Anyone else getting sci-fi vibes? #ScienceNews #Biotech #LifeAfterDeath #Science373Share
Ryan Lewis+FollowCancer Breakthrough, But Stock Drops?!Verastem just dropped some seriously promising cancer trial results—over 50% response in pancreatic cancer patients! But get this: their stock still fell 19%. Retail investors are suddenly bullish, and analysts are all in with ‘Buy’ ratings and a $15.75 price target (that’s 150% upside). The twist? Some think the China partnership is spooking the market. Wild how good news can still send stocks tumbling! #CancerResearch #StockMarket #Biotech #Health265Share
Jerry Clark+FollowThis Tiny Biotech Stock Went Wild—Should You Bite?Ever heard of a stock jumping 14,000% in a year? That’s what happened with Regencell, a Hong Kong company working on herbal remedies for ADHD and autism. Social media is buzzing, but here’s the catch: they haven’t sold any products yet, and most shares are held by insiders. Translation? It’s like a hot new sneaker drop—everyone’s talking, but only a few can actually buy. If you’re tempted, remember: what goes up super fast can crash just as hard. Would you risk it for a moonshot? #stockmarket #investing #biotech #Business10Share
Kelly Sanchez+FollowWould You Try a Smart Pain Implant?Imagine a future where a tiny, flexible implant not only tracks your pain in real time but also zaps it away with wireless electrical pulses—no bulky devices or constant doctor visits. This new tech could change the game for millions living with chronic pain. But would you trust a device like this inside your body? Is the convenience worth the potential risks? Let’s talk! #ChronicPain #BioTech #WearableTech #Tech10Share
Danielle Anderson+FollowWould You Bet on a $1.50 Biotech Stock?Editas Medicine’s stock has crashed 97% and now trades for about $1.50, but some Wall Street folks think it could double. The catch? Their main gene-editing treatment fizzled out because it was too complicated and pricey, plus rivals beat them to market. Now they’re pivoting to a new approach, but it’s super early days—think lottery ticket, not sure thing. If you’re feeling lucky, maybe grab a coffee and watch this one from the sidelines! #investing #biotech #stocks #Business00Share
Spencer Brewer+FollowModerna’s Combo Vax Hits a RoadblockModerna just yanked its FDA application for their much-hyped combo flu/COVID shot, even after saying it worked better than current vaccines. Turns out, the FDA wants more data, so Moderna’s pushing approval back to 2026 and deprioritizing the shot for now. Their stock dropped 4.5% on the news. They’ll try again later this year when more trial results come in. Meanwhile, the FDA’s getting stricter on vaccine approvals, and Pfizer’s racing ahead with its own combo vax. Wild times in vaccine land! #Moderna #VaccineNews #Biotech #FDA #COVID19 #Health10Share
